The greatest danger to public health might be “checkbook science”: research intended not to expand knowledge or to benefit humanity but to sell products.
Read More »Our Research & Training
We conduct research on the safety and effectiveness of medical products such as Alzheimer’s drugs, cancer drugs, and medical implants and devices used for a wide range of health problems, such as heart disease and joint replacement. In addition to the free information on this website and on www.stopcancerfund.org, we also publish articles in major medical journals and health policy journals.
These are the summaries of studies we’ve done, and here are the articles we’ve published in medical journals and health policy journals in the last few years.
Are you a reporter or medical writer interested in our free Health Research Training Workshop? Learn more here.
NCHR Report: The Health Risks of MRIs with Gadolinium-Based Contrast Agents
Gadolinium-based contrast agents can improve the diagnostic accuracy of MRIs, however gadolinium can stay in the body for months or years. There are many unanswered questions about who develops health problems related to gadolinium, how to determine if symptoms are due to gadolinium, and how to prevent or treat gadolinium-related conditions.
Read More »Breast Implant Illnesses: What’s the Evidence?
A large meta-analysis of the current cornerstone breast implant illnesses research studies reveals their weaknesses and highlights what is known.
Read More »Is TMS Proven Effective for Depression?
This report will examine how TMS became a frequently used treatment for depression in the United States despite what the research of the last decade shows about its very questionable effectiveness.
Read More »Are Medical Devices Studied on “Whites Only?” Do We Know What Works for Which Patients?
Are these high-risk implants studied on Whites only? Mostly younger white men? Groundbreaking study of high-risk medical devices finds lack of information for patients who are women, people of color, and over 65 years of age.
Read More »


